Medicenna Therapeutics Corp
TSX:MDNA

Watchlist Manager
Medicenna Therapeutics Corp Logo
Medicenna Therapeutics Corp
TSX:MDNA
Watchlist
Price: 1.01 CAD -0.98% Market Closed
Market Cap: 79m CAD

Intrinsic Value

There is not enough data to reliably calculate the intrinsic value of MDNA.

The Intrinsic Value is calculated as the average of DCF and Relative values:

MDNA Intrinsic Value
Not Available
Base Case Scenario
Compare MDNA to

Fundamental Analysis

Company Overview
Loading...
Economic Moat
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about MDNA?
Bearish
Neutral
Bullish
Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Balance Sheet Decomposition
Medicenna Therapeutics Corp

Current Assets 17.9m
Cash & Short-Term Investments 15.7m
Receivables 1.3m
Other Current Assets 861k
Non-Current Assets 169k
PP&E 120k
Intangibles 49k
Current Liabilities 4.5m
Accounts Payable 3.6m
Accrued Liabilities 751k
Other Current Liabilities 62k
Non-Current Liabilities 3.3m
Long-Term Debt 87k
Other Non-Current Liabilities 3.3m
Efficiency

Free Cash Flow Analysis
Medicenna Therapeutics Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Medicenna Therapeutics Corp

Revenue
0 CAD
Operating Expenses
-21.8m CAD
Operating Income
-21.8m CAD
Other Expenses
8m CAD
Net Income
-13.8m CAD
Fundamental Scores

MDNA Profitability Score
Profitability Due Diligence

Medicenna Therapeutics Corp's profitability score is hidden . The higher the profitability score, the more profitable the company is.

Exceptional 3Y Average ROIC
Exceptional ROIC
ROIC is Increasing
Low 3Y Average Gross Margin
hidden
Profitability
Score

Medicenna Therapeutics Corp's profitability score is hidden . The higher the profitability score, the more profitable the company is.

MDNA Solvency Score
Solvency Due Diligence

Medicenna Therapeutics Corp's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Short-Term Solvency
Negative Net Debt
Low D/E
Long-Term Solvency
hidden
Solvency
Score

Medicenna Therapeutics Corp's solvency score is hidden . The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MDNA Price Targets Summary
Medicenna Therapeutics Corp

Wall Street analysts forecast MDNA stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for MDNA is 5.02 CAD with a low forecast of 3.55 CAD and a high forecast of 8.85 CAD.

Lowest
Price Target
3.55 CAD
251% Upside
Average
Price Target
5.02 CAD
397% Upside
Highest
Price Target
8.85 CAD
776% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Medicenna Therapeutics Corp
does not pay dividends
Shareholder Yield

Current shareholder yield for MDNA is hidden .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
HIDDEN
Show
Dividend Yield
No dividends
Buyback Yield
HIDDEN
Debt Paydown Yield
HIDDEN

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y